Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Home
>
Blog
LATEST NEWS
First
North America Oral Anti
Oral Anti Diabetic Drug Market Trends From 2023
Low
Kidney disease and diabetes: Researchers find new predictive biomarker
Aug 11, 2023
First
read more
Aug 10, 2023
North America Oral Anti
read more
Aug 09, 2023
Oral Anti Diabetic Drug Market Trends From 2023
read more
Aug 08, 2023
Low
read more
Aug 07, 2023
Kidney disease and diabetes: Researchers find new predictive biomarker
read more
Aug 06, 2023
Analyst predicts strong growth for diabetic macular edema market
read more
Aug 05, 2023
Case Grows for SGLT2 Inhibitors as Gout Treatment
read more
Aug 04, 2023
Glucoberry Reviews
read more
Aug 03, 2023
Study discovers mechanism that inhibits a wide variety of viruses, similar to one already found in cancer drug
read more
Aug 02, 2023
Innovations and Collaborations Offer New Avenues for Growth in the Global Antiviral Drug Market to 2028
read more
Aug 01, 2023
Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
read more
Jul 31, 2023
Covid vaccines and antivirals are not enough
read more
first
1
2
3
4
5
6
7
last